Paint in Lucca, Tuscany with fellow artists. Our artists workshop offers one and two week art courses in and around the historical town of Lucca. The sessions focus on covering subjects such as still-life drawing, the figure and landscape. Artists and/or students of all skills levels have the opportunity to learn and create at the studio.
The program at the studio is unique because the groups are small, the quality of the art experience is high and the prices are probably more affordable than any other art workshop in Italy.
Even though the art schedule is the same for everyone, more experienced artists can pursue their own vision and create a body of work by that is more of a departure from the curriculum. The surroundings, culture and atmosphere in this region of Italy can certainly stimulate a renewed creative process.
We offer short workshops that run one, two or three days if you are in Lucca and would like to learn art during your stay. This shorter schedule allows you to take part in other activities during the week while still having a few days of art instruction in Tuscany.
2 day workshop – $390 (Begins on a studio day: Monday or Tuesday and your choice of second day from Wednesday thru Friday)
3 day workshop – $585 (Begins on a studio day: Monday or Tuesday and your choice of second and third day from Wednesday thru Friday)
hotel accommodations, airfare or other travel expenses. Students are responsible for booking both airfare and hotel.
Either a small set of high quality bristle brushes or an inexpensive set of long handle, nylon brushes will do just fine. We recommend a range of approximately 5 brushes: large flat, medium flat, medium round and two smaller flat and round brushes.
Ideally, Studio Borgo students will arrive at Lucca (by way of Pisa Galileo Galilei International Airport or by train) at least one day before the start of a week.
Starting on a Monday is not mandatory but it is encouraged. For maximum flexibility, students can join us for less than a week (four days or less).
Workshops are Monday-Friday from 9am – 2pm with a family style lunch on two studio days and a farewell dinner on Friday.
Meals are served outside the studio on the beautiful grounds overlooking the Serchio Valley. Mondays, Tuesdays and Fridays are in the Studio at Borgo a Mozzano.
The Artists’ Studio tailors workshops according to the desired media each student prefers to work in including drawing with graphite, charcoal, conte crayon and/or pastel and painting with oil or acrylic.
$187M, allergan, Allergan CEO Saunders could cash out Pfizer deal with $187M, Bloomberg figures, Brent Saunders, Pfizer deal
Even if Brent Saunders does not get the CEO role at Pfizer as a condition of Allergan agreeing to a buyout, which is reportedly being demanded, he will still get a huge payday from the deal. In the short time that he has been CEO of Allergan,Bloomberg figures he has collected shares and options that should allow him to cash out for nearly $190 million.
Sources have told Bloomberg that the two may announce a deal as early as next week in which Pfizer ($PFE) would buy Allergan ($AGN) for about $380 a share, a price that would make a deal worth roughly $150 billion. And after parsing the public filings, Bloomberg figures Saunders has about $187 million in compensation awards that he potentially could collect if it does happen at that share price.
Saunders, who became CEO of Actavis in July 2014, ahead of its Allergan buyout and name change, has $23 million in direct holdings, Bloomberg says. He also has stock options–some of which are exercisable and some which are not–that would be worth $97 million at the $380 price. Then are unvested restricted shares that would chip another $23 million in the pot as well as performance-based shares Bloomberg says would bring him $44 million at the target price. Add it all up and it comes to $187 million.
And that is if he were to just walk away. But Forbes‘ John LaMattina reported this week that sources tell him the negotiations were contingent on Saunders getting the top spot in a ‘Pfizergan’ hook up. As a former R&D chief at Pfizer, LaMattina has good sources.
Of course, a deal has not even been announced, no less completed. It could be upended by new tax rules from the Treasury Department which is trying to stop so-called tax inversion deals, which are costing the U.S. billions and billions of dollars. And there are lots of questions about whether Pfizer CEO Ian Read is ready to step down and how that all might play out. But if Saunders does get the job at what would be the world’s largest drugmaker, he could expect to get another really big compensation package.
Read last year was the 10th highest paid pharma exec with compensation of $23.28 million. But Saunders’ compensation package at Allergan last year was significantly higher than that. Saunders came in at number 3 with $36.61 million in 2014 compensation.